EU Gets Tough on ‘Research’ Unbundling

Mifid II will force sell-side firms to unbundle research fees from dealing commissions they charge to buy-side clients. The banks claim their front-office notes meet the criteria of being a minor non-monetary benefit, but EU watchdogs aren’t convinced, reports Risk.net’s Samuel Wilkes.

But three European Union national regulators warn that dealers should not assume they will be granted such an exemption. “[We] cannot share [the view] that material produced by a bank’s front office is automatically out of scope of Mifid II’s unbundling rules. An assessment of the material should be carried out, taking on board the aforementioned criteria, in order to determine whether the material qualifies as research or not in the context of Mifid II,” says a spokesperson for Spain’s Comisión

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here